REG - Spire Healthcare Grp - Update on shareholder views

Spire HealthcareAnnouncement

18/01/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220118:nRSR7113Ya&default-theme=true

RNS Number : 7113Y  Spire Healthcare Group PLC  18 January 2022

Spire Healthcare Group plc

 

('Spire Healthcare', 'the Company' or 'the Group')

 

Update on shareholder views

 

18 January 2022

 

Spire Healthcare Group plc (LSE: SPI), a leading UK independent hospital
group, today issues the following statement in accordance with Provision 4 of
the UK Corporate Governance Code ('the Code'):

 

Further to the shareholder vote at the General Meeting and the Court Meeting
held on 19 July 2021 in connection with the recommended cash offer for Spire
Healthcare by Ramsay Healthcare Limited, the Company is required by the Code
to issue an update. The Company sought and received feedback from certain key
shareholders at the time of the vote indicating their reasons for not
supporting the resolution. Given the exceptional and one-off nature of the
vote, the Company has not taken and does not propose to take any further steps
in respect of the matter.

 

- Ends -

 

For further information please contact:

 

Spire Healthcare

Angus Prentice - Interim Head of Investor Relations        +44 (0)7974
982 512

 

Instinctif Partners

Damian Reece
                      +44 (0)7931 598 593

Guy Scarborough
                   +44 (0)7917 178 920

Jeremy Durrant
                      +44 (0)7792 918 648

 

Registered Office and Head Office:

 

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

Registered number 09084066

 

About Spire Healthcare

 

Spire Healthcare is a leading independent hospital group in the United
Kingdom, with 40 private hospitals and eight clinics across England, Wales and
Scotland.

 

Working in partnership with around 7,500 experienced consultants, Spire
Healthcare delivered tailored, personalised care to almost 750,000 in-patients
and daycase patients in 2020, and is the leading private provider, by volume,
of knee and hip operations in the United Kingdom.

 

The Group's well-located and scalable hospitals have delivered successful and
award-winning clinical outcomes, positioning the Group well with patients,
consultants, the NHS, GPs and Private Medical Insurance ("PMI") providers. 93%
of Spire Healthcare's hospitals are rated 'Good' or 'Outstanding' by the CQC
(or the equivalent in Scotland and Wales).

 

Spire Healthcare treats patients through a variety of routes including PMI,
Self-pay and the NHS, providing the Group with diversified access to the
expected growth opportunities in the UK healthcare market, which faces
significant supply challenges as a result of NHS budget constraints and
increasing demand from a growing population with longer life expectancy.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFZGMMDNNGZZM